Morphine sulfate

Product NDC: 0228-3502
Requested package NDC: 0228-3502-11
11-digit product format: 002283502
Labeler code: 0228
Product ID: 0228-3502_30e79184-ceeb-4a0b-931f-7358f556987d
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Morphine sulfate
Dosage form: CAPSULE, EXTENDED RELEASE
Route: ORAL
Labeler: Actavis Pharma, Inc.
Application: NDA020616
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 2011-11-11
Marketing end: 2023-02-28
Substance: MORPHINE SULFATE
Active strength: 20 mg/1
Pharmacologic classes: Full Opioid Agonists [MoA], Opioid Agonist [EPC]
DEA schedule: CII
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	0228-3502	0228-3502-11	D	Discontinued by firm		2026-09-14

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 12 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N020616-001	KADIAN	MORPHINE SULFATE	20MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1996-07-03
N020616-002	KADIAN	MORPHINE SULFATE	50MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1996-07-03
N020616-003	KADIAN	MORPHINE SULFATE	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1996-07-03
N020616-004	KADIAN	MORPHINE SULFATE	30MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2001-03-09
N020616-005	KADIAN	MORPHINE SULFATE	60MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2001-03-09
N020616-006	KADIAN	MORPHINE SULFATE	80MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2006-10-27
N020616-007	KADIAN	MORPHINE SULFATE	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2007-02-27
N020616-008	KADIAN	MORPHINE SULFATE	10MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2007-04-20
N020616-009	KADIAN	MORPHINE SULFATE	40MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2012-07-09
N020616-010	KADIAN	MORPHINE SULFATE	70MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2012-07-09
N020616-011	KADIAN	MORPHINE SULFATE	130MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2012-07-09
N020616-012	KADIAN	MORPHINE SULFATE	150MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2012-07-09

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 13 · 516 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N020616-001	KADIAN	20MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1996-07-03	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020616-002	KADIAN	50MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1996-07-03	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020616-003	KADIAN	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1996-07-03	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020616-004	KADIAN	30MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2001-03-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020616-005	KADIAN	60MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2001-03-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020616-006	KADIAN	80MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2006-10-27	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020616-007	KADIAN	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2007-02-27	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020616-008	KADIAN	10MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2007-04-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020616-009	KADIAN	40MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2012-07-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020616-010	KADIAN	70MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2012-07-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020616-011	KADIAN	130MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2012-07-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020616-012	KADIAN	150MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2012-07-09	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N020616-001	KADIAN	20MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1996-07-03	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020616-002	KADIAN	50MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1996-07-03	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020616-003	KADIAN	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1996-07-03	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020616-004	KADIAN	30MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2001-03-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020616-005	KADIAN	60MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2001-03-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020616-006	KADIAN	80MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2006-10-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020616-007	KADIAN	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2007-02-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020616-008	KADIAN	10MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2007-04-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020616-009	KADIAN	40MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2012-07-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020616-010	KADIAN	70MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2012-07-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020616-011	KADIAN	130MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2012-07-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020616-012	KADIAN	150MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2012-07-09	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N020616-001	KADIAN	20MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1996-07-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020616-002	KADIAN	50MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1996-07-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020616-003	KADIAN	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1996-07-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020616-004	KADIAN	30MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2001-03-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020616-005	KADIAN	60MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2001-03-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020616-006	KADIAN	80MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2006-10-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020616-007	KADIAN	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2007-02-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020616-008	KADIAN	10MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2007-04-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020616-009	KADIAN	40MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2012-07-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020616-010	KADIAN	70MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2012-07-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020616-011	KADIAN	130MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2012-07-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020616-012	KADIAN	150MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2012-07-09	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020616-001	KADIAN	20MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1996-07-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020616-002	KADIAN	50MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1996-07-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020616-003	KADIAN	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1996-07-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020616-004	KADIAN	30MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	2001-03-09	`31067a03dcf5…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 68 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N020616-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020616-002	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020616-003	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020616-004	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020616-005	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020616-006	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020616-008	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020616-009	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020616-010	AB	1	`74a2ff9319b5…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020616-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020616-002	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020616-003	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020616-004	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020616-005	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020616-006	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020616-008	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020616-009	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020616-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N020616-002	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N020616-003	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N020616-004	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N020616-005	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N020616-006	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N020616-008	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N020616-009	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020616-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N020616-002	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N020616-003	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N020616-004	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N020616-005	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N020616-006	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N020616-008	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N020616-009	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020616-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N020616-002	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N020616-003	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N020616-004	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N020616-005	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N020616-006	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N020616-008	AB	1	`c0c555d07b60…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0228-3502-06	EA - Each	0228-3502	133ef36d-b316-4589-a42e-efd8f9a0973e	1	2014-08-01
0228-3502-11	EA - Each	0228-3502	40dd534c-603c-4eb6-a75b-952a5f6e9b55	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
MORPHINE SULFATE	ACTIVE INGREDIENT	X3P646A2J0	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
MORPHINE	ACTIVE MOIETY	76I7G6D29C	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
DIETHYL PHTHALATE	INACTIVE INGREDIENT	UF064M00AF	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
ETHYLCELLULOSES	INACTIVE INGREDIENT	7Z8S9VYZ4B	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
FD&C RED NO. 3	INACTIVE INGREDIENT	PN2ZH5LOQY	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
GELATIN	INACTIVE INGREDIENT	2G86QN327L	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
POTASSIUM HYDROXIDE	INACTIVE INGREDIENT	WZH3C48M4T	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
SHELLAC	INACTIVE INGREDIENT	46N107B71O	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
SUCROSE	INACTIVE INGREDIENT	C151H8M554	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC]	7

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
X3P646A2J0	MORPHINE SULFATE	6211-15-0	MORPHINE SULFATE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0228-3502-11	00228350211	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-3502-11)	2011-11-11	0000-00-00	No	No	Current